Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

New opportunities in emerging markets

Published in Pharma Exec January 2018 by Rachel Howard

Inizio

- PMLiVE

J&J extends its JLABS incubator scheme to Europe

The Belgian site will accommodate up to 30 life science start-ups

- PMLiVE

BioStrata expands leadership team

Helen Stewart-Miller and Craig Townsend are promoted into new roles

- PMLiVE

Professor Thomas Cech joins Storm Therapeutics

He takes up a scientific advisor role at the group

- PMLiVE

Notch Communications wins CPI account

Agency aims to make CPI a ‘household name’

- PMLiVE

FDA hands GSK a reprieve by blocking Novartis generic

The Advair rival could be delayed until 2019

Working with our healthcare system more closely is vital

Bayer’s Lars Bruening on partnership working amid environmental challenges

Risky business for pharma

China, Russia and Brazil are expected to provide the most issues

Lynch syndrome: a patient perspective

Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options,...

Blue Latitude Health

AI Voice Assistants

Battle of the Voice Assistants and Voice Search

At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

An agency called Owen

- PMLiVE

Gilead’s triple HIV drug approval prompts GSK lawsuit

ViiV claims bictegravir infringes its patent estate

- PMLiVE

J&J takes option on Theravance’s JAK drug in $1bn deal

TD-1473 has potential treating ulcerative colitis, Crohn’s and IBD patients

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links